Correction : Transaction in Own Shares

For immediate release

                                                               5 September 2007

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

              MARKET PURCHASE OF COMPANY'S OWN SHARES- CORRECTION              

Following an announcement that was made yesterday, the Company confirms that a
total of 456,000 and not 450,000 of the Company's own shares of 25p each were
purchased on 4 September 2007 for cancellation. The correct announcement should
read as follows:

Notification is given, pursuant to the authority granted at the Annual General
Meeting of the Company held on 9 July 2007 to make market purchases of the
Company's own shares up to an aggregate maximum of 7,557,925, that a market
total of 456,000 Ordinary shares of 25p each in the capital of the Company were
purchased on 4 September 2007 by the Company at a price of 483.00p per share.
Such shares will be cancelled.

Following this transaction and in conformity with the Transparency Directive's
transitional provision 6 the Company hereby notifies the market that: the total
number of Ordinary shares held by the Company in treasury following the
purchase is 5,192,100; and the total number of Ordinary shares that the Company
has in issue, less the total number of Ordinary shares held by the Company in
treasury following such purchase, and therefore, the total number of voting
rights in the Company is 49,039,468.

The figure of 49,039,468 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: [phone]